Skip to main content
SpringerLink
Log in

Polypharmacy, Aging and Potential Drug-Drug Interactions in Outpatients in Taiwan

A Retrospective Computerized Screening Study

  • Original Research Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Background

Polypharmacy is common in outpatients and has been identified as a major risk factor for drug-drug interactions (DDIs), which are an important cause of adverse drug reactions. There has been a rapid increase in the number of elderly patients worldwide. However, there have been few studies quantifying the impact of both patient age and the number of concomitant drugs prescribed on the probability of potential DDIs per person in general outpatients.

Objective

To assess the extent to which polypharmacy and aging are associated with potential DDIs in outpatients at a medical centre in Taiwan.

Methods

The medications of 81 650 outpatients who visited a medical centre in Taiwan between January 2004 and March 2004 were retrospectively screened for potential DDIs using a computerized drug-interaction program. The main inclusion criteria were a minimum of two drug prescriptions and duration of use of 14 or more days. We also analysed the DDI pattern, which included severity, level of documentation and onset of potential DDIs, and assessed the impact of the number of drugs prescribed and of aging on the prevalence of potential DDIs per person.

Results

The prevalence of potential DDIs was 25.6% (20 902 of 81 650). The mean±SD age of the 20 902 patients with potential DDIs was 57.5±16.5 years, and 47.6% of these patients were male. The mean±SD number of prescribed drugs in patients with potential DDIs was 5.8±2.4, and 67.7% of these patients were prescribed more than four drugs. The majority (55.7%) of DDIs were of the C2 pattern (severity: moderate; documentation: probable). The prevalence of potential DDIs increased in a linear mode with increasing age (p <0.001) and with the number of drugs prescribed (p <0.001); furthermore, in addition to being independently associated with potential DDIs, these two factors interacted to increase the risk further.

Conclusions

This study showed that approximately one-quarter of 81 650 outpatients who visited a medical centre in Taiwan over a period of 3 months in 2004 had potential DDIs. We observed independent increases in potential DDIs per person in association with aging and increasing number of prescribed drugs. Furthermore, a significant interaction between these two factors was observed: the effect of aging on the prevalence of potential DDIs increased as the number of prescribed drugs increased. Potential DDIs in outpatients can be reduced by minimizing the number of drugs prescribed following careful consideration of both their benefits and risks, particularly in the aging population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. von Euler M, Eliasson E, Ohlén G, et al. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf 2006; 15(3): 179–84

    Article  Google Scholar 

  2. Salazar JA, Poon I, Nair M. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 2007; 6(6): 695–704

    Article  PubMed  Google Scholar 

  3. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5(4): 345–51

    Article  PubMed  Google Scholar 

  4. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005; 17(4): 123–32

    Article  PubMed  Google Scholar 

  5. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005; 31(9): 4–11

    PubMed  Google Scholar 

  6. Zarowitz BJ, Stebelsky LA, Muma BK, et al. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005; 25(11): 1636–45

    Article  PubMed  Google Scholar 

  7. Brager R, Sloand E. The spectrum of polypharmacy. Nurse Pract 2005; 30(6): 44–50

    Article  PubMed  Google Scholar 

  8. Faries D, Ascher-Svanum H, Zhu B, et al. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 2005; 5: 26

    Article  PubMed  Google Scholar 

  9. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007; 370(9582): 185–91

    Article  PubMed  CAS  Google Scholar 

  10. Hohl CM, Dankoff J, Colacone A, et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38(6): 666–71

    Article  PubMed  CAS  Google Scholar 

  11. Bjorkman IK, Fastbom J, Schmidt IK, et al. Drug-drug interactions in the elderly. Ann Pharmacother 2002; 36(11): 1675–81

    Article  PubMed  CAS  Google Scholar 

  12. Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 2006; 4(2): 134–43

    Article  PubMed  Google Scholar 

  13. Fux R, Greiner D, Geldmacher M, et al. Multiple drug prescribing by general practitioners in a German region: implications for drug interactions and patient safety. Int J Clin Pharmacol Ther 2006; 44(11): 539–47

    PubMed  CAS  Google Scholar 

  14. Janchawee B, Wongpoowarak W, Owatranporn T, et al. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther 2005; 30(1): 13–20

    Article  PubMed  CAS  Google Scholar 

  15. Merlo J, Liedholm H, Lindblad U, et al. Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ 2001; 323(7310): 427–8

    Article  PubMed  CAS  Google Scholar 

  16. Solberg LI, Hurley JS, Roberts MH, et al. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data. Am J Manag Care 2004; 10 (11 Pt 1): 753–9

    PubMed  Google Scholar 

  17. Finkers F, Maring JG, Boersma F, et al. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther 2007; 32(5): 469–76

    Article  PubMed  CAS  Google Scholar 

  18. Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63(2): 187–95

    Article  PubMed  Google Scholar 

  19. Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006; 61(5): 511–5

    Article  PubMed  Google Scholar 

  20. Kohler GI, Bode-Böger SM, Busse R, et al. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000; 38(11): 504–13

    PubMed  CAS  Google Scholar 

  21. Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci 2006; 9(3): 427–33

    PubMed  CAS  Google Scholar 

  22. Tulner LR, Kuper IM, Frankfort SV, et al. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions. Am J Geriatr Pharmacother 2009; 7(2): 93–104

    Article  PubMed  Google Scholar 

  23. Nobili A, Pasina L, Tettamanti M, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther 2009; 34(4): 377–86

    Article  PubMed  CAS  Google Scholar 

  24. Cooney D, Pascuzzi K. Polypharmacy in the elderly: focus on drug interactions and adherence in hypertension. Clin Geriatr Med 2009; 25(2): 221–33

    Article  PubMed  Google Scholar 

  25. Tulner LR, Frankfort SV, Gijsen GJ, et al. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008; 25(4): 343–55

    Article  PubMed  Google Scholar 

  26. Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging 2008; 25(8): 683–92

    Article  PubMed  CAS  Google Scholar 

  27. Becker ML, Visser LE, van Gelder T, et al. Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged ≥55 years. Drugs Aging 2008; 25(2): 145–52

    Article  PubMed  Google Scholar 

  28. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007; 30(10): 911–8

    Article  PubMed  Google Scholar 

  29. Haider SI, Johnell K, Thorslund M, et al. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Ther 2007; 45(12): 643–53

    PubMed  CAS  Google Scholar 

  30. Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf 2006; 29(1): 79–90

    Article  PubMed  Google Scholar 

  31. Egger SS, Ratz Bravo AE, Hess L, et al. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins. Drugs Aging 2007; 24(5): 429–40

    Article  PubMed  CAS  Google Scholar 

  32. Thomson Micromedex. DRUG-REAX® system [online]. Available from URL: http://www.thomsonhc.com/home/dis-patch [Accessed 2002 Apr 30]

Download references

Acknowledgements

The authors have no conflicts of interest that are relevant to the content of this paper. This study was supported financially by the Shin Kong Wu Ho-Su Memorial Hospital. We thank Mei-Ling Shu, Dr Swu-Jane Lin and Dr Churn-Shiouh Gau for providing advice on the study and Lucy Yun-Ju Pan for proof-reading the manuscript.

Author information

Authors and Affiliations

  1. Department of Pharmacy, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan

    Chen-Fang Lin & Chun-Yu Wang

  2. School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan

    Chen-Fang Lin

  3. Central Laboratory, Shin Kong Wu Ho-Su Memorial Hospital, No. 95, Wen Chang Road, Shih Lin District, Taipei City, 111, Taiwan

    Chyi-Huey Bai (Associate Professor)

  4. School of Public Health, Taipei Medical University, Taipei, Taiwan

    Chyi-Huey Bai (Associate Professor)

Authors
  1. Chen-Fang Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chun-Yu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chyi-Huey Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chyi-Huey Bai.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, CF., Wang, CY. & Bai, CH. Polypharmacy, Aging and Potential Drug-Drug Interactions in Outpatients in Taiwan. Drugs Aging 28, 219–225 (2011). https://doi.org/10.2165/11586870-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11586870-000000000-00000

Keywords

Search

Navigation